New Data Shows Neuroprotective Benefits of ATH434 for MSA
source: pixabay.com

New Data Shows Neuroprotective Benefits of ATH434 for MSA

  In mid-July 2021, biotechnology company Alterity Therapeutics ("Alterity") shared the publication of new data regarding ATH434 for patients with multiple system atrophy (MSA). The data comes from a preclinical…

Continue Reading New Data Shows Neuroprotective Benefits of ATH434 for MSA
We Need to Improvement the Management and Care of NAFLD and NASH
source: pixabay.com

We Need to Improvement the Management and Care of NAFLD and NASH

Rare disease patients often face obstacles when it comes to the different aspects of care, whether that's diagnosis, screening, or management. Recent research from Baylor College of Medicine investigated the…

Continue Reading We Need to Improvement the Management and Care of NAFLD and NASH
DDX3X Linked to Anxiety, Self-Harm
source: pixabay.com

DDX3X Linked to Anxiety, Self-Harm

  Often misdiagnosed as other conditions such as Rett syndrome or cerebral palsy, DDX3X mutations cause both cognitive and physical difficulties. Since only an estimated 700 patients have been diagnosed…

Continue Reading DDX3X Linked to Anxiety, Self-Harm